Investment - Banking & Investment Services
Compare Stocks
5 / 10Stock Comparison
MGRB vs BEN vs IVZ vs VRTS vs CNNE
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Asset Management
Restaurants
MGRB vs BEN vs IVZ vs VRTS vs CNNE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Investment - Banking & Investment Services | Asset Management | Asset Management | Asset Management | Restaurants |
| Market Cap | $449M | $15.86B | $11.92B | $949M | $1.33B |
| Revenue (TTM) | $2.45B | $8.77B | $6.38B | $831M | $424M |
| Net Income (TTM) | $717M | $812M | $-243M | $138M | $-513M |
| Gross Margin | 86.0% | 80.3% | 43.2% | 74.9% | 0.0% |
| Operating Margin | 31.8% | 6.9% | -10.9% | 17.4% | -28.2% |
| Forward P/E | 0.5x | 11.2x | 10.4x | 5.5x | — |
| Total Debt | $2.69B | $13.30B | $10.12B | $2.84B | $332M |
| Cash & Equiv. | $586M | $3.57B | $1.98B | $477M | $182M |
MGRB vs BEN vs IVZ vs VRTS vs CNNE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 20 | May 26 | Return |
|---|---|---|---|
| Affiliated Managers… (MGRB) | 100 | 65.6 | -34.4% |
| Franklin Resources,… (BEN) | 100 | 150.0 | +50.0% |
| Invesco Ltd. (IVZ) | 100 | 235.1 | +135.1% |
| Virtus Investment P… (VRTS) | 100 | 102.3 | +2.3% |
| Cannae Holdings, In… (CNNE) | 100 | 37.5 | -62.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MGRB vs BEN vs IVZ vs VRTS vs CNNE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MGRB carries the broadest edge in this set and is the clearest fit for growth exposure and valuation efficiency.
- Rev growth 19.8%, EPS growth 50.3%
- PEG 0.01 vs VRTS's 0.38
- 19.8% NII/revenue growth vs VRTS's -8.0%
- Better valuation composite
BEN is the clearest fit if your priority is long-term compounding.
- 23.5% 10Y total return vs IVZ's 22.1%
IVZ is the #2 pick in this set and the best alternative if momentum is your priority.
- +93.1% vs CNNE's -18.8%
VRTS ranks third and is worth considering specifically for income & stability and defensive.
- Dividend streak 7 yrs, beta 1.14, yield 6.6%
- Beta 1.14, yield 6.6%, current ratio 3.80x
- 6.6% yield, 7-year raise streak, vs MGRB's 0.2%, (1 stock pays no dividend)
CNNE is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.98, Low D/E 33.5%, current ratio 2.07x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.8% NII/revenue growth vs VRTS's -8.0% | |
| Value | Better valuation composite | |
| Quality / Margins | 29.3% margin vs CNNE's -121.2% | |
| Stability / Safety | Beta 0.74 vs IVZ's 1.67, lower leverage | |
| Dividends | 6.6% yield, 7-year raise streak, vs MGRB's 0.2%, (1 stock pays no dividend) | |
| Momentum (1Y) | +93.1% vs CNNE's -18.8% | |
| Efficiency (ROA) | 8.0% ROA vs CNNE's -38.9%, ROIC 8.1% vs -5.7% |
MGRB vs BEN vs IVZ vs VRTS vs CNNE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
MGRB vs BEN vs IVZ vs VRTS vs CNNE — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MGRB leads in 3 of 6 categories
IVZ leads 1 • VRTS leads 1 • BEN leads 0 • CNNE leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MGRB leads this category, winning 5 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
BEN is the larger business by revenue, generating $8.8B annually — 20.7x CNNE's $424M. MGRB is the more profitable business, keeping 29.3% of every revenue dollar as net income compared to CNNE's -121.2%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.4B | $8.8B | $6.4B | $831M | $424M |
| EBITDAEarnings before interest/tax | $855M | $1.2B | $1.2B | $205M | $3M |
| Net IncomeAfter-tax profit | $717M | $812M | -$243M | $138M | -$513M |
| Free Cash FlowCash after capex | $978M | $938M | $1.9B | -$67M | -$35M |
| Gross MarginGross profit ÷ Revenue | +86.0% | +80.3% | +43.2% | +74.9% | +0.0% |
| Operating MarginEBIT ÷ Revenue | +31.8% | +6.9% | -10.9% | +17.4% | -28.2% |
| Net MarginNet income ÷ Revenue | +29.3% | +6.0% | -4.4% | +16.7% | -121.2% |
| FCF MarginFCF ÷ Revenue | +41.1% | +10.4% | +22.6% | -8.9% | -8.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | -6.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +149.1% | +100.0% | +34.2% | +10.9% | -160.8% |
Valuation Metrics
MGRB leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 0.7x trailing earnings, MGRB trades at a 98% valuation discount to BEN's 33.5x P/E. Adjusting for growth (PEG ratio), MGRB offers better value at 0.02x vs VRTS's 0.48x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $449M | $15.9B | $11.9B | $949M | $1.3B |
| Enterprise ValueMkt cap + debt − cash | $2.6B | $25.6B | $20.1B | $3.3B | $1.5B |
| Trailing P/EPrice ÷ TTM EPS | 0.74x | 33.54x | -16.77x | 7.10x | -1.54x |
| Forward P/EPrice ÷ next-FY EPS est. | 0.50x | 11.21x | 10.44x | 5.55x | — |
| PEG RatioP/E ÷ EPS growth rate | 0.02x | — | — | 0.48x | — |
| EV / EBITDAEnterprise value multiple | 2.70x | 22.53x | 16.34x | 16.20x | — |
| Price / SalesMarket cap ÷ Revenue | 0.18x | 1.81x | 1.87x | 1.14x | 3.13x |
| Price / BookPrice ÷ Book value/share | 0.13x | 1.11x | 0.94x | 0.95x | 0.80x |
| Price / FCFMarket cap ÷ FCF | 0.45x | 17.40x | 8.27x | — | — |
Profitability & Efficiency
MGRB leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
MGRB delivers a 16.0% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-52 for CNNE. CNNE carries lower financial leverage with a 0.33x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRTS's 2.74x. On the Piotroski fundamental quality scale (0–9), MGRB scores 8/9 vs CNNE's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +16.0% | +5.6% | -1.7% | +13.5% | -51.8% |
| ROA (TTM)Return on assets | +8.0% | +2.5% | -0.9% | +3.6% | -38.9% |
| ROICReturn on invested capital | +8.1% | +1.6% | -2.3% | +3.0% | -5.7% |
| ROCEReturn on capital employed | +8.6% | +2.0% | -2.6% | +3.7% | -7.3% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 6 | 6 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.61x | 0.94x | 0.78x | 2.74x | 0.33x |
| Net DebtTotal debt minus cash | $2.1B | $9.7B | $8.1B | $2.4B | $150M |
| Cash & Equiv.Liquid assets | $586M | $3.6B | $2.0B | $477M | $182M |
| Total DebtShort + long-term debt | $2.7B | $13.3B | $10.1B | $2.8B | $332M |
| Interest CoverageEBIT ÷ Interest expense | 9.69x | 15.19x | -6.19x | 2.15x | -25.50x |
Total Returns (Dividends Reinvested)
IVZ leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IVZ five years ago would be worth $10,825 today (with dividends reinvested), compared to $3,950 for CNNE. Over the past 12 months, IVZ leads with a +93.1% total return vs CNNE's -18.8%. The 3-year compound annual growth rate (CAGR) favors IVZ at 21.6% vs CNNE's -6.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -0.3% | +29.6% | +0.4% | -9.8% | -10.1% |
| 1-Year ReturnPast 12 months | +5.3% | +55.5% | +93.1% | -5.5% | -18.8% |
| 3-Year ReturnCumulative with dividends | +10.1% | +35.3% | +79.8% | +0.1% | -17.9% |
| 5-Year ReturnCumulative with dividends | -12.5% | +7.4% | +8.2% | -35.0% | -60.5% |
| 10-Year ReturnCumulative with dividends | -8.8% | +23.5% | +22.1% | +142.6% | -18.2% |
| CAGR (3Y)Annualised 3-year return | +3.2% | +10.6% | +21.6% | +0.0% | -6.3% |
Risk & Volatility
Evenly matched — MGRB and BEN each lead in 1 of 2 comparable metrics.
Risk & Volatility
MGRB is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than IVZ's 1.67 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BEN currently trades 97.1% from its 52-week high vs CNNE's 63.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.74x | 1.31x | 1.67x | 1.14x | 0.98x |
| 52-Week HighHighest price in past year | $19.10 | $31.44 | $29.61 | $215.06 | $21.96 |
| 52-Week LowLowest price in past year | $6.94 | $20.08 | $14.10 | $121.61 | $10.46 |
| % of 52W HighCurrent price vs 52-week peak | +88.0% | +97.1% | +90.6% | +65.9% | +63.7% |
| RSI (14)Momentum oscillator 0–100 | 61.0 | 78.4 | 69.4 | 55.4 | 65.6 |
| Avg Volume (50D)Average daily shares traded | 15K | 5.1M | 5.1M | 101K | 641K |
Analyst Outlook
VRTS leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BEN as "Hold", IVZ as "Hold", VRTS as "Hold", CNNE as "Buy". Consensus price targets imply 21.5% upside for CNNE (target: $17) vs -5.8% for BEN (target: $29). For income investors, VRTS offers the higher dividend yield at 6.58% vs MGRB's 0.18%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | — | $28.75 | $29.72 | $163.00 | $17.00 |
| # AnalystsCovering analysts | — | 27 | 28 | 11 | 5 |
| Dividend YieldAnnual dividend ÷ price | +0.2% | +4.3% | +3.1% | +6.6% | — |
| Dividend StreakConsecutive years of raises | 0 | 6 | 4 | 7 | 1 |
| Dividend / ShareAnnual DPS | $0.03 | $1.33 | $0.83 | $9.32 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +100.0% | +1.5% | +15.6% | +6.3% | 0.0% |
MGRB leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). IVZ leads in 1 (Total Returns). 1 tied.
MGRB vs BEN vs IVZ vs VRTS vs CNNE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MGRB or BEN or IVZ or VRTS or CNNE a better buy right now?
For growth investors, Affiliated Managers Group, Inc.
(MGRB) is the stronger pick with 19. 8% revenue growth year-over-year, versus -8. 0% for Virtus Investment Partners, Inc. (VRTS). Affiliated Managers Group, Inc. (MGRB) offers the better valuation at 0. 7x trailing P/E (0. 5x forward), making it the more compelling value choice. Analysts rate Cannae Holdings, Inc. (CNNE) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MGRB or BEN or IVZ or VRTS or CNNE?
On trailing P/E, Affiliated Managers Group, Inc.
(MGRB) is the cheapest at 0. 7x versus Franklin Resources, Inc. at 33. 5x. On forward P/E, Affiliated Managers Group, Inc. is actually cheaper at 0. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Affiliated Managers Group, Inc. wins at 0. 01x versus Virtus Investment Partners, Inc. 's 0. 38x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — MGRB or BEN or IVZ or VRTS or CNNE?
Over the past 5 years, Invesco Ltd.
(IVZ) delivered a total return of +8. 2%, compared to -60. 5% for Cannae Holdings, Inc. (CNNE). Over 10 years, the gap is even starker: VRTS returned +142. 6% versus CNNE's -18. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MGRB or BEN or IVZ or VRTS or CNNE?
By beta (market sensitivity over 5 years), Affiliated Managers Group, Inc.
(MGRB) is the lower-risk stock at 0. 74β versus Invesco Ltd. 's 1. 67β — meaning IVZ is approximately 125% more volatile than MGRB relative to the S&P 500. On balance sheet safety, Cannae Holdings, Inc. (CNNE) carries a lower debt/equity ratio of 33% versus 3% for Virtus Investment Partners, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — MGRB or BEN or IVZ or VRTS or CNNE?
By revenue growth (latest reported year), Affiliated Managers Group, Inc.
(MGRB) is pulling ahead at 19. 8% versus -8. 0% for Virtus Investment Partners, Inc. (VRTS). On earnings-per-share growth, the picture is similar: Affiliated Managers Group, Inc. grew EPS 50. 3% year-over-year, compared to -235. 6% for Invesco Ltd.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MGRB or BEN or IVZ or VRTS or CNNE?
Affiliated Managers Group, Inc.
(MGRB) is the more profitable company, earning 29. 3% net margin versus -99. 2% for Cannae Holdings, Inc. — meaning it keeps 29. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MGRB leads at 31. 8% versus -28. 2% for CNNE. At the gross margin level — before operating expenses — MGRB leads at 86. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MGRB or BEN or IVZ or VRTS or CNNE more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Affiliated Managers Group, Inc. (MGRB) is the more undervalued stock at a PEG of 0. 01x versus Virtus Investment Partners, Inc. 's 0. 38x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Affiliated Managers Group, Inc. (MGRB) trades at 0. 5x forward P/E versus 11. 2x for Franklin Resources, Inc. — 10. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CNNE: 21. 5% to $17. 00.
08Which pays a better dividend — MGRB or BEN or IVZ or VRTS or CNNE?
In this comparison, VRTS (6.
6% yield), BEN (4. 3% yield), IVZ (3. 1% yield), MGRB (0. 2% yield) pay a dividend. CNNE does not pay a meaningful dividend and should not be held primarily for income.
09Is MGRB or BEN or IVZ or VRTS or CNNE better for a retirement portfolio?
For long-horizon retirement investors, Virtus Investment Partners, Inc.
(VRTS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 14), 6. 6% yield, +142. 6% 10Y return). Invesco Ltd. (IVZ) carries a higher beta of 1. 67 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VRTS: +142. 6%, IVZ: +22. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MGRB and BEN and IVZ and VRTS and CNNE?
These companies operate in different sectors (MGRB (Financial Services) and BEN (Financial Services) and IVZ (Financial Services) and VRTS (Financial Services) and CNNE (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MGRB is a small-cap high-growth stock; BEN is a mid-cap income-oriented stock; IVZ is a mid-cap income-oriented stock; VRTS is a small-cap deep-value stock; CNNE is a small-cap quality compounder stock. BEN, IVZ, VRTS pay a dividend while MGRB, CNNE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.